Toward the Future: A Race‐Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing
Clinical Pharmacology & Therapeutics · 2026-09 · 120 (3) · 639-647
DOI: 10.1002/cpt.70358 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 11.06.2026. Verfasst von Marc H Scheetz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Pharmacology, Pharmacometrics Center of Excellence, Midwestern University, Downers Grove Campus, Chicago College …. Hauptthemen laut MEDLINE: Glomerular Filtration Rate, Precision Medicine, Kidney. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Accurate assessment of renal function is fundamental to dosing renally eliminated drugs. For decades, serum creatinine–based estimating equations have been used to approximate glomerular filtration rate (GFR) for this purpose. While these equations perform reasonably well at the population level, they exhibit substantial individual‐level imprecision and inaccuracy. Simultaneously, recent efforts to remove race from estimating equations addressed important ethical concerns but did not resolve the core limitation of population‐based estimation for individual drug dosing. In this perspective, we argue that personalized dosing requires a shift away from demographic surrogates toward direct measurement of renal clearance and clarify when incremental therapeutic complexity is warranted. We review the limitations of endogenous biomarkers, discuss the role of cystatin C, and propose exogenously measured GFR using iohexol integrated within a Bayesian pharmacometric framework as a clinically actionable approach to individualized drug dosing. Practically, this framework can be implemented by administering a small iohexol dose, collecting sparse timed samples, estimating absolute mGFR and its uncertainty with Bayesian software, and using that posterior estimate to refine renal dose selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Pharmacology, Pharmacometrics Center of Excellence, Midwestern University, Downers Grove Campus, Chicago College of Pharmacy, Downers Grove, Illinois, USA.
- Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA.
- Albany College of Pharmacy and Health Sciences, Albany, New York, USA.
- Stratton VA Medical Center, Albany, New York, USA.
- University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA.
- Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Marc H Scheetz, Thomas P Lodise, Nathaniel J Rhodes, Manjunath P Pai, Erin F Barreto, Michael N Neely
Zitieren
APA
Scheetz, M. H., Lodise, T. P., Rhodes, N. J., Pai, M. P., Barreto, E. F., & Neely, M. N. (2026). Toward the Future: A Race‐Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing. Clinical Pharmacology & Therapeutics, 120(3), 639-647. https://doi.org/10.1002/cpt.70358
Vancouver
Scheetz MH, Lodise TP, Rhodes NJ, Pai MP, Barreto EF, Neely MN. Toward the Future: A Race‐Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing. Clinical Pharmacology & Therapeutics. 2026;120(3):639-647. doi:10.1002/cpt.70358
BibTeX
@article{Scheetz2026,
author = {Scheetz, Marc H and Lodise, Thomas P and Rhodes, Nathaniel J and Pai, Manjunath P and Barreto, Erin F and Neely, Michael N},
title = {Toward the Future: A Race‐Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing},
journal = {Clinical Pharmacology & Therapeutics},
year = {2026},
volume = {120},
number = {3},
pages = {639--647},
doi = {10.1002/cpt.70358}
}
EUVIMED